Medical research
FDA: Men should be included in breast cancer clinical trials
Men should be included in clinical trials of new breast cancer treatments, the U.S. Food and Drug Administration says.
Aug 27, 2019
0
28
News tagged with cancer drug development
Oncology & Cancer
New study helps to understand human defense mechanisms and spread of cancer
With the help of new technology, the researchers of the University of Turku in Finland have gained more detailed information on the diversity of the human lymphatic system than before. The research results can help to understand ...
Aug 13, 2019
0
1
Oncology & Cancer
Clinical trial identifies new breast cancer drug as a potential therapy for glioblastoma
The Ivy Brain Tumor Center at the Barrow Neurological Institute, has released the results of its recent Phase 0 clinical trial of the breast cancer drug ribociclib (Kisqali) for the treatment of recurrent glioblastoma. The ...
Jul 25, 2019
0
8
Oncology & Cancer
Study reveals genetic similarities of osteosarcoma between dogs and children
A bone cancer known as osteosarcoma is genetically similar in dogs and human children, according to the results of a study published today by Tufts University and the Translational Genomics Research Institute (TGen), an affiliate ...
Jul 19, 2019
0
4
Oncology & Cancer
FDA approves personalized therapy for metastatic bladder cancer
(HealthDay)—The first personalized treatment for patients with metastatic bladder cancer and susceptible fibroblast growth factor receptor (FGFR) genetic alterations was granted accelerated approval by the U.S. Food and ...
Apr 15, 2019
0
1
Oncology & Cancer
Scientists decipher 3-D structure of a promising molecular target for cancer treatment
Columbia University scientists, in collaboration with researchers from Nimbus Therapeutics, have demystified a metabolic enzyme that could be the next major molecular target in cancer treatment.
Apr 3, 2019
0
34
Oncology & Cancer
Precision-targeted liposomes curb triple-negative breast cancer, metastases in mice
Some 15 to 20 percent of all breast cancers are triple-negative, meaning they lack receptors for estrogen, progesterone and human epidermal growth factor type 2. They have the worst prognosis of all breast cancers and very ...
Mar 20, 2019
0
25
Oncology & Cancer
A groundbreaking pancreatic cancer trial, which aims to match patients with more targeted and effective treatment
A groundbreaking pancreatic cancer trial, which aims to match patients with more targeted and effective treatment for their tumours, has successfully recruited its 100th patient.
Mar 20, 2019
0
14
Oncology & Cancer
Scientists advise caution in immunotherapy research
In a new study, Yale Cancer Center (YCC) scientists suggest that as the number of clinical trials in cancer immunotherapy grows exponentially, some caution should be exercised as we continue to better understand the biology ...
Dec 20, 2018
0
12
Oncology & Cancer
Study discovers 40 new genetic variants associated with colorectal cancer risk
The most comprehensive genome-wide association study, or GWAS, of colorectal cancer risk to date, published today in Nature Genetics, has discovered 40 new genetic variants and validated 55 previously identified variants ...
Dec 3, 2018
0
115
